CVS HEALTH Corp

CVS

Share price not shown yet: live market data is not connected. Everything below comes from CVS’s own SEC filings.

View options chain →

Fundamentals

SEC filings

Ratios that need a share price (P/E, PEG, P/S, dividend yield) are not shown yet, because live market data is not connected. Everything below comes from filed financials.

Rule of 40
10%
rev growth + FCF margin
Revenue growth
+7.4%
TTM vs prior TTM
FCF margin
2.8%
ROE (TTM)
6.2%
TTM NI ÷ avg equity
Net debt
$47.5B
total debt − cash & ST inv.
Dilution (YoY)
+0.8%
negative = buybacks
SBC / revenue
0.2%
TTM revenue
$415B

Revenue

$0B$20B$40B$60B$80B$100BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$106B

EPS (diluted)

$-2.00$0.00$2.00Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$2.31

Operating

-4%-2%0%2%4%6%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’264%

Net income

-$4B-$2B$0B$2BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$3B

Net margin

-4%-2%0%2%4%Dec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’263%

Free cash flow vs. stock-based comp

FCFSBC
$0B$5BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$6B

Operating cash flow vs. capex

OCFCapex
-$2B$0B$2B$4B$6B$8B$10BDec ’21Sep ’22Jun ’23Mar ’24Dec ’24Sep ’25Jun ’26$6B

Insider activity

SEC Form 4
Reading Form 4 filings from SEC EDGAR…